The DOI matches its Crossref record; 396 of the 396 references it cites were found in a registry or an index.
Intestinal permeation enhancers for oral peptide delivery
Open accessAbstract
Intestinal permeation enhancers (PEs) are one of the most widely tested strategies to improve oral delivery of therapeutic peptides. This article assesses the intestinal permeation enhancement action of over 250 PEs that have been tested in intestinal delivery models. In depth analysis of pre-clinical data is presented for PEs as components of proprietary delivery systems that have progressed to clinical trials. Given the importance of co-presentation of sufficiently high concentrations of PE and peptide at the small intestinal epithelium, there is an emphasis on studies where PEs have been formulated with poorly permeable molecules in solid dosage forms and lipoidal dispersions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–396 of 396
Eldor, R., Arbit, E., Corcos, A., & Kidron, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059524 · Cited by 94
Guggi, D., Krauland, A. H., & Bernkop‐Schnürch, A. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00299-2 · Cited by 93
Enhancement of Colonic Drug Absorption by the Paracellular Permeation Route
Tomita, M., Shiga, M., Hayashi, M., & Awazu, S. (1988) · Pharmaceutical Research · doi:10.1023/a:1015999309353 · Cited by 93
Film coatings for oral colon delivery
Maroni, A., Curto, M. D. D., Zema, L., Foppoli, A. A., & Gazzaniga, A. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.05.043 · Cited by 92
Toorisaka, E. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00674-9 · Cited by 92
Chopra, A. R., Kommagani, R., Saha, P. K., Louet, J., Salazar, C., Song, J., Jeong, J., Finegold, M. J., Viollet, B., DeMayo, F. J., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2010.12.001 · Cited by 90
Collares‐Buzato, C. B., McEwan, G. T. A., Jepson, M. A., Simmons, N. L., & Hirst, B. H. (1994) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(94)90163-5 · Cited by 90
Biopharmaceutics Applications in Drug Development
Krishna, R., & Yu, L. X. (2007) · Springer eBooks · doi:10.1007/978-0-387-72379-2 · Cited by 90
Maresca, M., Mahfoud, R., Pfohl‐Leszkowicz, A., & Fantini, J. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9254 · Cited by 88
Constantinides, P. P., & Yiv, S. H. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)00272-7 · Cited by 88
Challenges in the Delivery of Peptide drugs: an Industry Perspective
Lewis, A. L., & Richard, J. (2015) · Therapeutic Delivery · doi:10.4155/tde.14.111 · Cited by 88
Karsdal, M. A., Henriksen, K., Bay‐Jensen, A., Molloy, B., Arnold, M., John, M. R., Byrjalsen, I., Azria, M., Riis, B. J., Qvist, P., et al. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010372625 · Cited by 88
Constantinides, P. P., Welzel, G., Ellens, H. M., Smith, P. L., Sturgis, S., Yiv, S. H., & Owen, A. B. (1996) · Pharmaceutical Research · doi:10.1023/a:1016030812272 · Cited by 87
Oral Delivery of Biologically Active Parathyroid Hormone
Leone‐Bay, A., Sato, M., Paton, D. R., Hunt, A. H., Sarubbi, D., Carozza, M., Chou, J., McDonough, J., & Baughman, R. (2001) · Pharmaceutical Research · doi:10.1023/a:1010936227570 · Cited by 87
Gopalakrishnan, S., PANDEY, N., Tamiz, A. P., Vere, J., CARRASCO, R., Somerville, R. P. T., TRIPATHI, A., Ginski, M. J., Paterson, B. F., & Alkan, Ş. Ş. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.08.047 · Cited by 87
Walsh, E. G., Adamczyk, B. E., Chalasani, K. B., Maher, S., O‘Toole, E. B., Fox, J. S., Leonard, T. W., & Brayden, D. J. (2011) · Therapeutic Delivery · doi:10.4155/tde.11.132 · Cited by 86
Self-citationWelling, S. H., Hubálek, F., Jacobsen, J. B., Brayden, D. J., Rahbek, U. L., & Buckley, S. T. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.12.017 · Cited by 86
Self-citationEpithelial Barrier Defects in HT‐29/B6 Colonic Cell Monolayers Induced by Tumor Necrosis Factor‐α
Gitter, A. H., Bendfeldt, K., SCHMITZ, H., Schulzke, J., Bentzel, C. J., & Fromm, M. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05242.x · Cited by 86
Behets, C., Williams, J. M., Chappard, D., Devogelaer, J., & Manicourt, D.-H. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040609 · Cited by 85
Brayden, D. J., Gleeson, J. P., & Walsh, E. G. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.10.008 · Cited by 85
Self-citationThe absorption of insulin from various regions of the rat intestine
Kidron, M., Bar-On, H., Berry, E. M., & Ziv, E. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90673-7 · Cited by 84
Shao, Z., Li, Y., Chermak, T., & Mitra, A. K. (1994) · Pharmaceutical Research · doi:10.1023/a:1018997101542 · Cited by 83
Cell-Penetrating Peptides: Methods and Protocols
(2010) · Methods in molecular biology · doi:10.1007/978-1-60761-919-2 · Cited by 82
Toxicity of Excipients—A Food and Drug Administration Perspective
Osterberg, R. E., & See, N. A. (2003) · International Journal of Toxicology · doi:10.1177/109158180302200507 · Cited by 81
Gerhard, R., Schmidt, G., Hofmann, F., & Aktories, K. (1998) · Infection and Immunity · doi:10.1128/iai.66.11.5125-5131.1998 · Cited by 81
Hurni, M. A., Noach, A. B. J., Blom-Roosemalen, M. C. M., Boer, A. G. D., Nagelkerke, J. F., & Breimer, D. D. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39367-5 · Cited by 80
Intestinal Absorption of Octreotide Using Trimethyl Chitosan Chloride: Studies in Pigs
Thanou, M., Verhoef, J. C., Verheijden, J. H. M., et al. (2001) · Pharmaceutical Research · doi:10.1023/a:1011092613951 · Cited by 79
Brayden, D. J., Creed, E., O’Connell, A. W., Leipold, H. R., Agarwal, R., & Leone‐Bay, A. (1997) · Pharmaceutical Research · doi:10.1023/a:1012192115828 · Cited by 79
Self-citationRubinstein, A., & Tirosh, B. (1994) · Pharmaceutical Research · doi:10.1023/a:1018961204325 · Cited by 79
A claudin-4 modulator enhances the mucosal absorption of a biologically active peptide
Uchida, H., Kondoh, M., Hanada, T., Takahashi, A., Hamakubo, T., & Yagi, K. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.01.010 · Cited by 78
Boegh, M., García-Díaz, M., Müllertz, A., & Nielsen, H. M. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.01.014 · Cited by 78
Penetratin Derivative-Based Nanocomplexes for Enhanced Intestinal Insulin Delivery
Zhu, X. D., Shan, W., Zhang, P., Jin, Y., Guan, S., Fan, T., Yang, Y., Zhou, Z., & Huang, Y. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400493b · Cited by 78
CXCL8 modulates human intestinal epithelial cells through a CXCR1 dependent pathway
Sturm, A. (2004) · Cytokine · doi:10.1016/j.cyto.2004.09.007 · Cited by 77
Čilek, A., Çelebi, N., & Tırnaksız, F. (2006) · Drug Delivery · doi:10.1080/10717540500313109 · Cited by 76
Larazotide acetate promotes tight junction assembly in epithelial cells
Gopalakrishnan, S., Tripathi, A. K., Tamiz, A. P., Alkan, Ş. Ş., & Pandey, N. B. (2012) · Peptides · doi:10.1016/j.peptides.2012.02.016 · Cited by 75
Noach, A. B. J., Kurosaki, Y., Blom-Roosemalen, M. C. M., de Boer, A. G., & Breimer, D. D. (1993) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(93)90195-l · Cited by 74
A permeation enhancer for increasing transport of therapeutic macromolecules across the intestine
Gupta, V., Hwang, B. H., Doshi, N., & Mitragotri, S. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.05.002 · Cited by 74
A novel per‐oral insulin formulation: proof of concept study in non‐diabetic subjects
Kidron, M., Dinh, S. M., Menachem, Y., Abbas, R., Variano, B., Goldberg, M., Arbit, E., & Bar-On, H. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01160.x · Cited by 74
Regulation of paracellular permeability in Caco-2 cell monolayers by protein kinase C
Stenson, W. F., Easom, R. A., Riehl, T. E., & TURK, J. W. (1993) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1993.265.5.g955 · Cited by 74
Kinetic studies of the interaction of fatty acids with phosphatidylcholine vesicles (liposomes)
Rogerson, M., Robinson, B. H., Bucak, Ş., & Walde, P. (2006) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2006.01.001 · Cited by 73
Feighery, L. M., Cochrane, S. W., Quinn, T., Baird, A. W., O’Toole, D. P., Owens, S. E., O’Donoghue, D. P., Mrsny, R. J., & Brayden, D. J. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9527-6 · Cited by 73
Self-citationStaat, C., Coisne, C., Dabrowski, S., Stamatovic, S. M., Andjelkovic, A. V., Wolburg, H., Engelhardt, B., & Blasig, I. E. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.03.007 · Cited by 71
Rivera, T., Leone‐Bay, A., Paton, D. R., Leipold, H. R., & Baughman, R. (1997) · Pharmaceutical Research · doi:10.1023/a:1012160703533 · Cited by 70
Taverner, A., Dondi, R., Almansour, K., Laurent, F., Owens, S. E., Eggleston, I. M., Fotaki, N., & Mrsny, R. J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.05.270 · Cited by 70
Self-citationMechanistic Analysis of Chemical Permeation Enhancers for Oral Drug Delivery
Whitehead, K. A., & Mitragotri, S. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9542-2 · Cited by 70
Formulation Strategies to Improve Oral Peptide Delivery
Maher, S., Ryan, B. K., Duffy, A. M., & Brayden, D. J. (2014) · Pharmaceutical Patent Analyst · doi:10.4155/ppa.14.15 · Cited by 70
Self-citationIn vitro and in vivo analysis of the mechanism of absorption enhancement by palmitoylcarnitine.
Hochman, J. H., Fix, J. A., & LeCluyse, E. L. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38767-7 · Cited by 70
Role of tight-junctional pathways in bile salt-induced increases in colonic permeability
Freel, R. W., Hatch, M., Earnest, D. L., & Goldner, A. M. (1983) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1983.245.6.g816 · Cited by 70
Khedkar, A., Iyer, H., Anand, A. C., Verma, M., Krishnamurthy, S., Savale, S. S., & Atignal, A. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01213.x · Cited by 69
Restitution of barrier and transport function of porcine colon after acute mucosal injury
Argenzio, R. A., Henrikson, C. K., & Liacos, J. A. (1988) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1988.255.1.g62 · Cited by 69
Makagiansar, I. T., Avery, M., Hu, Y., Audus, K. L., & Siahaan, T. J. (2001) · Pharmaceutical Research · doi:10.1023/a:1011094025008 · Cited by 68
Tight Junctions and the Intestinal Barrier
Ma, T. Y., Anderson, J. M., & Turner, J. R. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382026-6.00038-5 · Cited by 68
Leone‐Bay, A., Ho, K.-K., Agarwal, R., Baughman, R., Chaudhary, K., DeMorin, F., Genoble, L., McInnes, C., Lercara, C., Milstein, S., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960038f · Cited by 67
Thiolated chitosan: Development and in vitro evaluation of an oral delivery system for acyclovir
Palmberger, T. F., Hombach, J., & Bernkop‐Schnürch, A. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.07.004 · Cited by 67
Kamei, N., Onuki, Y., Takayama, K., & Takeda‐Morishita, M. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23708 · Cited by 66
Intravail™: highly effective intranasal delivery of peptide and protein drugs
Maggio, E. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.4.529 · Cited by 66
A role for intracellular calcium in tight junction reassembly after ATP depletion-repletion
Ye, J., Tsukamoto, T., Sun, A. M., & Nigám, S. K. (1999) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1999.277.4.f524 · Cited by 65
Sharma, P. K., Varma, M. V. S., Chawla, H. P. S., & Panchagnula, R. (2005) · Il Farmaco · doi:10.1016/j.farmac.2005.08.008 · Cited by 65
Liu, H., Tang, R., Pan, W., Zhang, Y., & Liu, H. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357022052 · Cited by 65
Strickley, R. G., & Anderson, B. D. (1996) · Pharmaceutical Research · doi:10.1023/a:1016043715791 · Cited by 64
Karsdal, M. A., Byrjalsen, I., Riis, B. J., & Christiansen, C. (2008) · BMC Clinical Pharmacology · doi:10.1186/1472-6904-8-5 · Cited by 63
Raoof, A. A., Ramtoola, Z., McKenna, B., Yu, R. Z., Hardee, G. E., & Geary, R. S. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00162-8 · Cited by 62
van der Merwe, S. M., Verhoef, J. C., Kotzé, A. F., & Junginger, H. E. (2003) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(03)00152-8 · Cited by 62
Petersen, S. B., Nolan, G., Maher, S., Rahbek, U. L., Guldbrandt, M., & Brayden, D. J. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.08.010 · Cited by 62
Self-citationOkada, T., Narai, A., Matsunaga, S., Fusetani, N., & Shimizu, M. (2000) · Toxicology in Vitro · doi:10.1016/s0887-2333(00)00014-x · Cited by 61
Fetih, G. N., Habib, F., Okada, N., Fujita, T., Attia, M., & Yamamoto, A. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.05.017 · Cited by 61
Thanou, M., Henderson, S., Kydonieus, A. F., & Elson, C. M. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.11.002 · Cited by 61
Yamamoto, A., Tatsumi, H., Maruyama, M., Uchiyama, T., Okada, N., & Fujita, T. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29666-x · Cited by 61
Hamid, K. A., Katsumi, H., Sakane, T., et al. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.06.018 · Cited by 60
Viljoen, J. M., Steenekamp, J. H., Marais, A. F., et al. (2013) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2013.782501 · Cited by 60
LeCluyse, E. L., Appel, L. E., & Sutton, S. C. (1991) · Pharmaceutical Research · doi:10.1023/a:1015838508656 · Cited by 58
Effects of absorption promoters on insulin absorption through colon-targeted delivery
Katsuma, M., Watanabe, S., Kawai, H., Takemura, S., & Sako, K. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.09.028 · Cited by 58
Acylated non-α-amino acids as novel agents for the oral delivery of heparin sodium, USP
Leone‐Bay, A. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00101-6 · Cited by 58
Koga, K., Takarada, N., & Takada, K. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.09.004 · Cited by 57
Absorption-Enhancing Effects of Sodium Caprate and Palmitoyl Carnitine in Rat and Human Colons
Shimazaki, T., Tomita, M., Sadahiro, S., et al. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1018835829643 · Cited by 56
Dorkoosh, F. A., Verhoef, J. C., Verheijden, J. H. M., Rafiee‐Tehrani, M., Borchard, G., & Junginger, H. E. (2002) · Pharmaceutical Research · doi:10.1023/a:1020416918624 · Cited by 56
Enteral absorption of octreotide: absorption enhancement by polyoxyethylene‐24‐cholesterol ether
Drewe, J., Fricker, G., Vonderscher, J., & Beglinger, C. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb12799.x · Cited by 56
Chansanroj, K., & Betz, G. (2010) · Acta Biomaterialia · doi:10.1016/j.actbio.2010.01.044 · Cited by 56
Tazuke, Y., Drongowski, R. A., Teitelbaum, D. H., & Coran, A. G. (2003) · Pediatric Surgery International · doi:10.1007/s00383-003-1003-8 · Cited by 55
Structural requirements of penetratin absorption enhancement efficiency for insulin delivery
Khafagy, E., Morishita, M., Ida, N., Nishio, R., Isowa, K., & Takayama, K. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.019 · Cited by 55
A mechanistic study on enhancement of rectal permeability to insulin in the albino rabbit.
Yamamoto, A., Hayakawa, E., Kato, Y., Nishiura, A., & Lee, V. H. L. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10333-9 · Cited by 55
Nitric Oxide Donors Enhance Rectal Absorption of Macromolecules in Rabbits
Utoguchi, N., Watanabe, Y., Shida, T., et al. (1998) · Pharmaceutical Research · doi:10.1023/a:1011920530771 · Cited by 54
Creation and biochemical analysis of a broad-specific claudin binder
Takahashi, A., Saito, Y., Kondoh, M., Matsushita, K., Krug, S. M., Suzuki, H., Tsujino, H., Li, X., Aoyama, H., Matsuhisa, K., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.01.017 · Cited by 54
Pharmacokinetics and Pharmacodynamics of Oral Heparin Solid Dosage Form in Healthy Human Subjects
Mousa, S. A., Zhang, F., Aljada, A., Chaturvedi, S., Takieddin, M., Zhang, H., Chi, L., Castelli, M., Friedman, K., Goldberg, M. M., et al. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270007307242 · Cited by 54
Intestinal Drug Transport Enhancement byAloe vera
Chen, W., Lu, Z., Viljoen, A. M., & Hamman, J. H. (2009) · Planta Medica · doi:10.1055/s-0029-1185341 · Cited by 53
SONG, K., FASANO, A., & Eddington, N. D. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.09.011 · Cited by 53
Wang, X., Maher, S., & Brayden, D. J. (2010) · Therapeutic Delivery · doi:10.4155/tde.10.5 · Cited by 53
Self-citationThe use of thiolated polymers as carrier matrix in oral peptide delivery—Proof of concept
Bernkop‐Schnürch, A., Pinter, Y., Guggi, D., Kahlbacher, H., Schöffmann, G., Schuh, M., Schmerold, I., Curto, M. D. D., D'Antonio, M., Esposito, P., et al. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.04.004 · Cited by 53
Alani, A. W. G., & Robinson, J. R. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9438-6 · Cited by 52
Effects of absorption enhancers on cytoskeletal actin filaments in Caco-2 cell monolayers
Sakai, M., Imai, T., Ohtake, H., Azuma, H., & Otagiri, M. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00235-5 · Cited by 52
Currently Marketed Oral Lipid-Based Dosage Forms: Drug Products and Excipients
Strickley, R. G. (2007) · CRC Press eBooks · doi:10.3109/9781420017267-4 · Cited by 52
Sugibayashi, K., Onuki, Y., & Takayama, K. (2008) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.09.011 · Cited by 51
Brayden, D. J., Maher, S., Bahar, B., & Walsh, E. G. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.05.013 · Cited by 50
Self-citationSuzuki, A., Morishita, M., Kajita, M., Takayama, K., Isowa, K., Chiba, Y., Tokiwa, S., & Nagai, T. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980125q · Cited by 50
Karsdal, M. A., Byrjalsen, I., Riis, B., & Christiansen, C. (2008) · BMC Clinical Pharmacology · doi:10.1186/1472-6904-8-12 · Cited by 50
Kamei, N., Morishita, M., Ehara, J., & Takayama, K. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.07.016 · Cited by 49
Kamei, N., Kikuchi, S., Takeda‐Morishita, M., Terasawa, Y., Yasuda, A., Yamamoto, S., Ida, N., Nishio, R., & Takayama, K. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23364 · Cited by 49
Ion pair absorption of ionized drugs —fact or fiction ?
Jonkman, J. H. G., & Hunt, C. A. (1983) · Pharmacy World & Science · doi:10.1007/bf01960074 · Cited by 48
Enhancement of Intestinal Model Compound Transport by DS-1, a Modified Quillaja Saponin
Chao, A. C., Nguyen, J. V., Broughall, M., Recchia, J., Kensil, C. R., Daddona, P. E., & Fix, J. A. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js9800735 · Cited by 48
Sakai, K., Kutsuna, T., Nishino, T., Fujihara, Y., & Yata, N. (1986) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600750414 · Cited by 47
The mycotoxin patulin, modulates tight junctions in caco-2 cells
McLaughlin, J. T., Lambert, D., Padfield, P. J., Burt, J. P. H., & O’Neill, C. A. (2008) · Toxicology in Vitro · doi:10.1016/j.tiv.2008.10.009 · Cited by 47
Lee, S., Lee, J., Lee, D. Y., Kim, S., Lee, Y.-J., & Byun, Y. (2005) · Diabetologia · doi:10.1007/s00125-004-1658-2 · Cited by 44
Enhancement of jejunal and colonic absorption of fosfomycin by promoters in the rat
Ishizawa, T., Hayashi, M., & Awazu, S. (1987) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1987.tb03124.x · Cited by 44
Rhamnolipids enhance epithelial permeability in Caco-2 monolayers
Jiang, L., Long, X., & Meng, Q. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.02.003 · Cited by 44
Reversible disassembly of an intestinal epithelial monolayer by prolonged exposure to phorbol ester
Hecht, G. A., Robinson, B., & Koutsouris, A. (1994) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1994.266.2.g214 · Cited by 44
Transcellular and Lipophilic Complex-Enhanced Intestinal Absorption of Human Growth Hormone
Wu, S.-J., & Robinson, J. R. (1999) · Pharmaceutical Research · doi:10.1023/a:1014809916407 · Cited by 43
Hämmerle, S. P., Mindeholm, L., Launonen, A., et al. (2012) · Bone · doi:10.1016/j.bone.2012.01.009 · Cited by 43
Maher, S., Wang, X., Bzik, V. A., McClean, S., & Brayden, D. J. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.07.011 · Cited by 43
Self-citationGradauer, K., Nishiumi, A., Unrinin, K., Higashino, H., Kataoka, M., Pedersen, B. L., Buckley, S. T., & Yamashita, S. (2015) · Molecular Pharmaceutics · doi:10.1021/mp500776a · Cited by 43
Fukui, A., Naito, Y., Handa, O., Kugai, M., Tsuji, T., Yoriki, H., Qin, Y., Adachi, S., Higashimura, Y., Mizushima, K., et al. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00236.2012 · Cited by 43
Marquette, S., Peerboom, C., Yates, A. S., Denis, L., Goole, J., & Amighi, K. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.10.013 · Cited by 42
Vaishya, R. D., Mandal, A., Gokulgandhi, M. R., Patel, S. P., & Mitra, A. K. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.04.075 · Cited by 42
Li, P., Nielsen, H. M., Fanø, M., & Müllertz, A. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23640 · Cited by 42
Foradori, A., Mezzano, S. A., Videla, C., Pefaur, J., & Elberg, A. J. (1998) · Transplantation Proceedings · doi:10.1016/s0041-1345(98)00393-5 · Cited by 41
Oral multiple w/o/w emulsion formulation of a peptide salmon calcitonin: in vitro-in vivo evaluation
Dogru, S. T., Çalış, S., & Öner, F. (2000) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2000.00306.x · Cited by 41
Gabor, F., Fillafer, C., Neutsch, L., Ratzinger, G., & Wirth, M. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-00477-3_12 · Cited by 41
Oral Delivery of Sodium Cromolyn: Preliminary Studies In Vivo and In Vitro
Leone‐Bay, A., Leipold, H. R., Sarubbi, D., Variano, B., Rivera, T., & Baughman, R. (1996) · Pharmaceutical Research · doi:10.1023/a:1016034913181 · Cited by 40
Investigation of coco-glucoside as a novel intestinal permeation enhancer in rat models
Aguirre, T. A. S., Rosa, M., Guterres, S. S., Pohlmann, A. R., Coulter, I. S., & Brayden, D. J. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.10.013 · Cited by 40
Self-citationWang, T., Wang, N., Hao, A., He, X., Li, T., & Deng, Y. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.01.006 · Cited by 40
The mycotoxin patulin increases colonic epithelial permeability in vitro
Mohan, H. M., Collins, D., Maher, S., Walsh, E. G., Winter, D. C., O'Brien, P. J., Brayden, D. J., & Baird, A. W. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.07.036 · Cited by 40
Self-citationThiomer: A potential carrier for therapeutic delivery
Kumar, R., & Sinha, V. R. (2013) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2013.04.008 · Cited by 40
Ramakrishna, B., Mathan, M., & Mathan, V. I. (1994) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529409090437 · Cited by 40
Effect of Oleic Acid Vesicles on Intestinal Absorption of Carboxyfluorescein in Rats
Murakami, M., Yoshikawa, H., Takada, K., & Muranishi, S. (1986) · Pharmaceutical Research · doi:10.1023/a:1016368714631 · Cited by 39
Lee, Y.-H., Perry, B. A., Labruno, S., Lee, H. S., Stern, W., Falzone, L. M., & Sinko, P. J. (1999) · Pharmaceutical Research · doi:10.1023/a:1014849630520 · Cited by 39
Hegg, P. (1979) · Biochimica et Biophysica Acta (BBA) - Protein Structure · doi:10.1016/0005-2795(79)90088-6 · Cited by 39
Influence of food intake on the bioavailability and efficacy of oral calcitonin
Karsdal, M. A., Byrjalsen, I., Azria, M., Arnold, M., Choi, L., Riis, B. J., & Christiansen, C. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03371.x · Cited by 39
Oral Delivery of Macromolecular Drugs: Barriers, Strategies and Future Trends
Bernkop‐Schnürch, A. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0200-9 · Cited by 39
Khafagy, E., Iwamae, R., Kamei, N., & Takeda‐Morishita, M. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9804-y · Cited by 38
Schasteen, C. S., Donovan, M. G., & Cogburn, J. N. (1992) · Journal of Controlled Release · doi:10.1016/0168-3659(92)90007-e · Cited by 38
Binkley, N., Bone, H. G., Gilligan, J. P., & Krause, D. S. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2796-0 · Cited by 38
Transport studies of insulin across rat jejunum in the presence of chicken and duck ovomucoids
Agarwal, V., Nazzal, S., Reddy, I. K., & Khan, M. A. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011776522 · Cited by 38
Effect of Growth Factors on Epithelial Restitution of Human Colonic Mucosa in Vitro
Riegler, M. F., Sedivy, R., Sogukoglu, T., Cosentini, E. P., Bischof, G., Teleky, B., Feil, W., Schffissel, R., Hamilton, G., & Wenzl, E. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709011204 · Cited by 38
Hovgaard, L., BRØNDSTED, H. V., & Nielsen, H. M. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)00232-t · Cited by 37
Eldor, R., Kidron, M., & Arbit, E. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01153.x · Cited by 37
Fricker, G., Fahr, A., Beglinger, C., Kissel, T., Reiter, G., & Drewe, J. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15177.x · Cited by 37
Development of a colonic release capsule dosage form and the absorption of insulin.
Kraeling, M. E. K., & Ritschel, W. A. (1992) · PubMed · Cited by 36
Swenson, E. S., Milisen, W. B., & Curatolo, W. J. (1994) · Pharmaceutical Research · doi:10.1023/a:1018920728800 · Cited by 36
Solubilisation of hydrophilic drugs in oily formulations
New, R. R. C., & Kirby, C. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00491-7 · Cited by 36
A mechanistic analysis of carrier-mediated oral delivery of protein therapeutics
Stoll, B. R., Leipold, H. R., Milstein, S., & Edwards, D. A. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00144-3 · Cited by 36
Oral administration of insulin included in fine W/O/W emulsions to rats
Shima, M., Tanaka, M., Fujii, T., Egawa, K., Kimura, Y., Adachi, S., & Matsuno, R. (2005) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2005.05.002 · Cited by 36
Hess, S., Rotshild, V., & Hoffman, A. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.03.003 · Cited by 36
Ilbäck, N. ‐., Nyblom, M., Carlfors, J., Aspenström-Fagerlund, B., Tavelin, S., & Glynn, A. W. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2003.10.037 · Cited by 35
Mori, S., Matsuura, A., Prasad, Y. V. R., & Takada, K. (2004) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.27.418 · Cited by 35
Fetih, G. N., Lindberg, S., Itoh, K., Okada, N., Fujita, T., Habib, F., Artersson, P., Attia, M., & Yamamoto, A. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.12.017 · Cited by 35
Liu, D., Kobayashi, T., Russo, S. M., Li, F., Plevy, S. E., Gambling, T. M., Carson, J. L., & Mumper, R. J. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9441-7 · Cited by 35
Doi, N., Tomita, M., & Hayashi, M. (2010) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-10-rg-071 · Cited by 35
Suzuki, T., & Hara, H. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.01.044 · Cited by 35
Maggio, E., & Grasso, P. (2011) · Regulatory Peptides · doi:10.1016/j.regpep.2011.02.009 · Cited by 35
LeCluyse, E. L., Sutton, S. C., & Fix, J. A. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38218-2 · Cited by 35
A phosphorylation hotspot within the occludin C‐terminal domain
Dörfel, M. J., & Huber, O. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06536.x · Cited by 34
Reversible opening of the blood-brain barrier by anti-bacterial antibodies.
TUOMANEN, E. I., Prasad, S. M., George, J. S., Hoepelman, A. I. M., Ibsen, P. H., Heron, I., & Starzyk, R. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.16.7824 · Cited by 34
Detergent-enabled transport of proteins and nucleic acids through hydrophobic solvents.
Bromberg, L. E., & Klibanov, A. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.1.143 · Cited by 34
Oil-based formulations for oral delivery of insulin
Li, C., & Deng, Y. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357044175 · Cited by 34
Morimoto, K., Akatsuchi, H., Morisaka, K., & KAMADA, A. (1985) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1985.tb04963.x · Cited by 34
Agarwal, V., Reddy, I. K., & Khan, M. A. (2000) · Pharmacy and Pharmacology Communications · doi:10.1211/146080800128735935 · Cited by 34
Lee, S., Kim, S. K., Lee, D. Y., Chae, S. Y., & Byun, Y. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.5.1869-1871.2006 · Cited by 34
Role of the mucous/glycocalyx layers in insulin permeation across the rat ileal membrane
Aoki, Y., Morishita, M., & Takayama, K. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.03.004 · Cited by 33
Brayden, D. J., & Walsh, E. G. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9634-3 · Cited by 33
Self-citationMalik, S., Canaham, D. H., & Gouda, M. W. (1975) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600640620 · Cited by 33
Tight Junctions and the Intestinal Barrier
Ma, T. Y., & Anderson, J. M. (2006) · Elsevier eBooks · doi:10.1016/b978-012088394-3/50064-7 · Cited by 33
Narkar, Y., Burnette, R. R., Bleher, R., Albrecht, R. M., Kandela, A., & Robinson, J. R. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9509-8 · Cited by 32
Kamm, W., Jonczyk, A., Jung, T., Luckenbach, G., Raddatz, P., & Kissel, T. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(99)00092-5 · Cited by 32
Subchronic Oral Toxicity of Salcaprozate Sodium (SNAC) in Sprague-Dawley and Wistar Rats
Riley, M. G. I., Castelli, M., & Paehler, E. A. (2009) · International Journal of Toxicology · doi:10.1177/1091581809337737 · Cited by 32
Maher, S., Feighery, L. M., Brayden, D. J., & McClean, S. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9246-z · Cited by 32
Self-citationLundin, P., Bojrup, M., Ljusberg‐Wahren, H., Weström, B. R., & Lundin, S. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36863-6 · Cited by 30
Nakanishi, K., Masada, M., & NADAI, T. (1983) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.31.4161 · Cited by 30
Cox, A. B., Rawlinson, L.-A. B., Baird, A. W., Bzik, V. A., & Brayden, D. J. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9354-9 · Cited by 29
Self-citationMahmud, F., Jeon, O., Al-Hilal, T. A., Kweon, S., Yang, V. C.-M., Lee, D. S., & Byun, Y. (2015) · Molecular Pharmaceutics · doi:10.1021/mp500626a · Cited by 29
Watari, A., Hasegawa, M., Yagi, K., & Kondoh, M. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.12.012 · Cited by 29
Yang, T., Arnold, J. J., & Ahsan, F. (2005) · Journal of drug targeting · doi:10.1080/10611860400020191 · Cited by 29
Colonic absorption of salmon calcitonin using tetradecyl maltoside (TDM) as a permeation enhancer
Petersen, S. B., Nielsen, L. G., Rahbek, U. L., Guldbrandt, M., & Brayden, D. J. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.01.009 · Cited by 28
Self-citationTsutsumi, K., Li, S. K., Hymas, R. V., Teng, C., Tillman, L., Hardee, G. E., Higuchi, W. I., & Ho, N. F. H. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21093 · Cited by 28
Sugiyama, T., Yamamoto, A., KAWABE, Y., et al. (1997) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.20.812 · Cited by 28
Welling, S. H., Clemmensen, L. K. H., Buckley, S. T., Hovgaard, L., Brockhoff, P. B., & Refsgaard, H. H. F. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.05.012 · Cited by 27
Spermine affects intestinal in vitro permeability to different-sized molecules in rats
Osman, N., Weström, B. R., Wang, Q., Persson, L., & Karlsson, B. W. (1998) · Comparative Biochemistry and Physiology Part C Pharmacology Toxicology and Endocrinology · doi:10.1016/s0742-8413(98)00042-5 · Cited by 27
Aguirre, T. A. S., Rosa, M., Coulter, I. S., & Brayden, D. J. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.09.001 · Cited by 26
Self-citationLee, Y.-H., Perry, B. A., Sutyak, J. P., Stern, W., & Sinko, P. J. (2000) · Pharmaceutical Research · doi:10.1023/a:1007596821702 · Cited by 24
Diabetes Correction in Pancreatectomized Canines by Orally Absorbable Insulin−Deoxycholate Complex
Kim, S. K., Lee, S., Jin, S., Moon, H. T., Jeon, O. C., Lee, D. Y., & Byun, Y. (2010) · Molecular Pharmaceutics · doi:10.1021/mp9002688 · Cited by 24
Preliminary evaluation of a novel oral delivery system for rhPTH1-34: In vitro and in vivo
Guo, L., Erli, M., Zhao, H., Long, Y., Zheng, C., & Duan, M. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.08.029 · Cited by 24
Enhancement of paracellular transport of heparin disaccharide across Caco-2 cell monolayers
Cho, S. Y., Kim, J. S., Li, H., et al. (2002) · Archives of Pharmacal Research · doi:10.1007/bf02975268 · Cited by 21
González‐Mariscal, L., Hernández, S., & Vega, J. (2008) · Recent Patents on Drug Delivery & Formulation · doi:10.2174/187221108784534117 · Cited by 21
Lee, H. J., & Amidon, G. L. (2002) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.302 · Cited by 20
Uchida, T., TOIDA, Y., SAKAKIBARA, S., Miyanaga, Y., TANAKA, H., Nishikata, M., Tazuya, K., Yasuda, N., & Matsuyama, K. (2001) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.49.1261 · Cited by 20
Fetih, G. N., Habib, F., Katsumi, H., Okada, N., Fujita, T., Attia, M., & Yamamoto, A. (2006) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.21.222 · Cited by 20
Safety of the Cell-Penetrating Peptide Penetratin as an Oral Absorption Enhancer
Nielsen, E. J. B., Kamei, N., & Takeda‐Morishita, M. (2015) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b14-00517 · Cited by 18
Younessi, P., Avadi, M. R., Shamimi, K., Sadeghi, A. M. M., Moezi, L., Nahid, E., Bayati, K., Dehpour, A. R., & Rafiee‐Tehrani, M. (2004) · PubMed · Cited by 18
Zhang, W., Parniak, M. A., Sarafianos, S. G., Empey, P. E., & Rohan, L. C. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.03.022 · Cited by 17
Li, X., Saeki, R., Watari, A., et al. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.10.018 · Cited by 16
Chao, A. C., Taylor, M. T., Daddona, P. E., Broughall, M., & Fix, J. A. (1998) · Journal of drug targeting · doi:10.3109/10611869808997879 · Cited by 15
SAKAI, I., Tozaki, H., MATASUMOTO, K., Ito, Y., Fujita, T., Murakami, M., Muranishi, S., & Yamamoto, A. (1999) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.22.611 · Cited by 13
Kowari, K., Hirosawa, I., Kurai, H., Utoguchi, N., Fujii, M., & Watanabe, Y. (2002) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.25.678 · Cited by 13
Shima, M., Kimura, Y., Adachi, S., & Matsuno, R. (1999) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.63.680 · Cited by 12
Epithelial Barrier Modulation by a Channel Forming Peptide
Somasekharan, S., Brandt, R., Iwamoto, T., Tomich, J. M., & Schultz, B. D. (2008) · The Journal of Membrane Biology · doi:10.1007/s00232-008-9099-3 · Cited by 12
Marušič, M., Zupančič, T., Hribar, G., Komel, R., Anderluh, G., & Caserman, S. (2013) · New Biotechnology · doi:10.1016/j.nbt.2013.05.008 · Cited by 9
Surendran, N., Nguyen, L. D., Giuliano, A. R., & Blanchard, J. D. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840302 · Cited by 8
Davidson, M. B. (2009) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328322f92e · Cited by 5
Cited by
The Current State of Peptide Drug Discovery: Back to the Future?
Henninot, A., Collins, J. C., & Nuss, J. M. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00318 · Cited by 1,113
Advances in oral peptide therapeutics
Drucker, D. J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0053-0 · Cited by 646
Transcellular Stomach Absorption of a Derivatized Glucagon-Like Peptide-1 Receptor Agonist
Buckley, S. T., Bækdal, T. A., Vegge, A., Maarbjerg, S. J., Pyke, C., Ahnfelt-Rønne, J., Madsen, K. G., Schéele, S. G., Alanentalo, T., Kirk, R. K., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aar7047 · Cited by 553
Xu, Q., Hong, H., Wu, J., & Yan, X. (2019) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2019.02.050 · Cited by 368
Oral delivery of proteins and peptides: Challenges, status quo and future perspectives
Zhu, Q., Chen, Z., Paul, P. K., Lu, Y., Wu, W., & Qi, J. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.04.001 · Cited by 353
Metadata
- Authors
- Maher, S., Mrsny, R. J., & Brayden, D. J.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2016-11
- Volume
- 106
- Issue
- Pt B
- Pages
- 277-319
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2433570839
- Cited by
- 381
- References
- 396
- FWCI
- 1.85
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.